Apotex Wants In On Orphan Drug Suit To Protect Generic
Apotex Inc. on Monday asked a D.C. federal court for permission to intervene in Eagle Pharmaceutical Inc.'s suit accusing the FDA of wrongly denying it orphan drug exclusivity for the chemotherapy...To view the full article, register now.
Already a subscriber? Click here to view full article